Bluejay Diagnostics, Inc. (BJDX)

USD 2.58

(4.03%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - 249.04 Thousand - - -
Cost of Revenue 780.95 Thousand 200.12 Thousand 145.71 Thousand 157.03 Thousand 142.97 Thousand
Gross Profit -780.95 Thousand 48.91 Thousand -145.71 Thousand -157.03 Thousand -142.97 Thousand
Operating Expenses 10.31 Million 9.36 Million 3.15 Million 1.19 Million 1.63 Million
Selling, General and Administrative Expenses 4.59 Million 5.21 Million 2.08 Million 669.13 Thousand 1.17 Million
Research and Development Expenses 5.71 Million 4.15 Million 1.14 Million 527.25 Thousand 454.61 Thousand
Other Expenses - 258.13 Thousand -75 Thousand 5537.00 749.44 Thousand
Cost and Expenses 10.31 Million 9.56 Million 3.15 Million 1.19 Million 1.63 Million
Operating Income -10.31 Million -9.31 Million -3.23 Million -1.19 Million -1.63 Million
Interest Expense - - 367.45 Thousand 26.99 Thousand -
Income Tax Expense - -69.05 Thousand 241.38 Thousand -32.56 Thousand -62.12 Thousand
Earnings before Tax -9.95 Million -9.29 Million -3.48 Million -1.15 Million -819.84 Thousand
Net Income -9.95 Million -9.22 Million -3.72 Million -1.12 Million -757.71 Thousand
Earnings Per Share Basic -72.62 -73.22 -29.67 -14.19 -9.55
Earnings Per Share Diluted -72.62 -73.22 -29.67 -14.19 -9.55
Weighted Average Shares Outstanding 137.06 Thousand 126.02 Thousand 125.7 Thousand 79.33 Thousand 79.33 Thousand
Weighted Average Shares Outstanding (Diluted) 137.06 Thousand 126.02 Thousand 125.7 Thousand 79.33 Thousand 79.33 Thousand
Gross Margin - 0.20 - - -
EBIT Margin - -36.38 - - -
Profit Margin - -37.05 - - -
EBITDA -9.17 Million -8.99 Million -3.08 Million -1.03 Million -1.48 Million
Earnings Before Tax Margin - -37.41 - - -

Income Statement Charts